IVEMEND 150 mg powder for solution for infusion, Aprepitant Placebo Tablet, Aprepitant Teva 80 mg, harde capsules, NaCl I.V.
Phase 3 small_molecule active
Quick answer
IVEMEND 150 mg powder for solution for infusion, Aprepitant Placebo Tablet, Aprepitant Teva 80 mg, harde capsules, NaCl I.V. for Delayed chemotherapy induced nausea and vomiting (CINV) is a Phase 3 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AXIM BIOTECHNOLOGIES, INC.
- Indication
- Delayed chemotherapy induced nausea and vomiting (CINV)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active